| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |